Most Gulf markets fell on fears of a Fed rate cut, according to Reuters.
Written by: Muhammad Manzar Hussain (Reuters) – Most Gulf stock markets fell on Sunday after U.S. economic data and comments ...
Read more
Saudi Arabia stocks rise at close of trade; Tadawul All Shares by Investing.com up 0.18%
Investing.com – Saudi Arabia stocks were higher after the close on Sunday, as shares and sectors rose. At the close ...
Read more
Ascentage Pharma has announced a New Drug Application for its novel Bcl-2 Inhibitor Lisaftoclax that has been accepted and recommended by the China NMPA of CDE for Priority Review Designation.
ROCKVILLE, Md. And Suzhou, China, November 17, 2024 /PRNewswire/ — Essentage Pharma (6855.HK), a global biopharmaceutical company primarily engaged in ...
Read more
How Donald Trump’s Allies Benefit from the Resurgence of ‘Anti-Week’
A group of allies in Donald Trump’s inner circle are trying to capitalize on his re-election and a resurgent mega-movement ...
Read more
Finding the money to make Europe great again
Stay informed with free updates Sign up on the bus. Geopolitics myFT Digest — delivered straight to your inbox. As ...
Read more
Thames Water’s emergency loan could cost £800 million in interest and fees.
Thames Water could be burdened with more than £800mn in interest and other costs on its planned £3bn emergency debt, ...
Read more
Bernard Arnault’s son steps into a new chapter in the LVMH succession story.
When pop star Katy Perry performed in jeweler Tiffany’s signature shade of robin’s egg blue at the reopening of the ...
Read more
Donald Trump’s victory threatens to disrupt G20 initiatives.
Unlock Editor Digest for free. Rola Khalaf, editor of the FT, selects her favorite stories in this weekly newsletter. The ...
Read more
Russia resold more gas to Europe after cutting off Austria, sources, data from Reuters show
By Jason Howitt, Thomas Askert and Dmitry Zhdanikov BERLIN/PRAGUE/LONDON (Reuters) – Russian gas flows to Austria were suspended for a ...
Read more
At AASLD The Liver Meeting ® 2024, Carisma Therapeutics promises new preclinical data on engineered macrophages to treat liver fibrosis.
New preclinical findings support the antifibrotic potential of engineered macrophages in several fibrosis models. Engineered TIM4-expressing macrophages correct defective efferocytosis ...
Read more
